Vous avez cherché: glatiramer (Anglais - Slovène)

glatiramer acetate
(0,55; 0,93)

combination with beta-interferons or glatiramer acetate.
kombinacija z interferoni beta ali glatiramer acetatom.

the number of relapses per patient per year for glatiramer acetate was 0.3.
pri zdravljenju z glatiramer acetatom je bilo število recidivov na bolnika na leto 0,3.

gilenya can generally be started immediately after discontinuation of interferon or glatiramer acetate.
zdravljenje z zdravilom gilenya je običajno mogoče začeti takoj po prekinitvi zdravljenja z interferonom oziroma z glatiramer acetatom,

glatiramer acetate was approved for marketing in the u.k. in august 2000, and launched in december.
glatiramer povzroči premik populacije limfocitov t iz oblike proinflamatornih celic pomagalk th1 v regulatorne celice th2, ki zavirajo vnetni odziv.

for medicinal products such as interferon and glatiramer acetate, concomitant exposure of this duration was not associated with safety risks in clinical trials.
v kliničnih preskušanjih sočasna izpostavljenost zdravilom, kot sta interferon in glatiramer acetat, v tem času ni pokazala povezave s tveganjem za varnost.

administration of glatiramer shifts the population of t cells from pro-inflammatory th1 cells to regulatory th2 cells that suppress the inflammatory response.
== mehanizem delovanja ==glatiramer acetat je naključni polimer iz 4 aminokislin, ki se nahajajo v mielinskem bazičnem proteinu.

in a second main study involving 1,417 patients, patients were given tecfidera, placebo or another medicine, glatiramer acetate.
v drugi glavni študiji, v kateri je sodelovalo 1 417 bolnikov, so bolnikom dajali zdravilo tecfidera, placebo ali drugo zdravilo, imenovano glatiramer acetat.

tysabri must not be given with beta-interferon or glatiramer acetate (other long-term medicines for ms).
zdravilo tysabri se ne sme dajati z interferonom beta ali glatiramer acetatom (drugi vrsti zdravil za dolgotrajno zdravljenje ms).

based on the clinical data related to concomitant administration of teriflunomide with interferon beta or with glatiramer acetate, no waiting period is required when initiating teriflunomide after interferon beta or glatiramer acetate or when starting interferon beta or glatiramer acetate, after teriflunomide.
na osnovi kliničnih podatkov v zvezi s sočasno uporabo teriflunomida in interferona beta ali glatiramer acetata ni potrebno čakati, če želite uvesti teriflunomid po zdravljenju z interferonom beta ali glatiramer acetatom ali če želite uvesti interferon beta ali glatiramer acetat po zdravljenju s teriflunomidom.

commonly used medicinal products in patients with multiple sclerosis, intramuscular interferon beta-1a and glatiramer acetate, were clinically tested for potential interactions with dimethyl fumarate and did not alter the pharmacokinetic profile of dimethyl fumarate.
zdravili, ki se pri bolnikih z multiplo sklerozo pogosto uporabljajo, intramuskularni interferon beta-1a in glatiramer acetat, so klinično preskusili glede možnih medsebojnih delovanj z dimetilfumaratom; spremembe farmakokinetičnega profila dimetilfumarata niso ugotovili.

==l03a immunostimulants=====l03aa colony stimulating factors===:l03aa02 filgrastim:l03aa03 molgramostim:l03aa09 sargramostim:l03aa10 lenograstim:l03aa12 ancestim:l03aa13 pegfilgrastim:l03aa14 lipegfilgrastim:l03aa15 balugrastim:ql03aa90 pegbovigrastim===l03ab interferons===:l03ab01 interferon alfa natural:l03ab02 interferon beta natural:l03ab03 interferon gamma:l03ab04 interferon alfa-2a:l03ab05 interferon alfa-2b:l03ab06 interferon alfa-n1:l03ab07 interferon beta-1a:l03ab08 interferon beta-1b:l03ab09 interferon alfacon-1:l03ab10 peginterferon alfa-2b:l03ab11 peginterferon alfa-2a:l03ab12 albinterferon alfa-2b:l03ab13 peginterferon beta-1a:l03ab14 cepeginterferon alfa-2b:l03ab60 peginterferon alfa-2b, combinations:l03ab61 peginterferon alfa-2a, combinations:ql03ab90 interferon omega, feline origin===l03ac interleukins===:l03ac01 aldesleukin:l03ac02 oprelvekin===l03ax other immunostimulants===:l03ax01 lentinan:l03ax02 roquinimex:l03ax03 bcg vaccine:l03ax04 pegademase:l03ax05 pidotimod:l03ax07:l03ax08 poly iclc:l03ax09 thymopentin:l03ax10 immunocyanin:l03ax11 tasonermin:l03ax12 melanoma vaccine:l03ax13 glatiramer acetate:l03ax14 histamine dihydrochloride:l03ax15 mifamurtide:l03ax16 plerixafor:l03ax17 sipuleucel-t:l03ax18 cridanimod:l03ax19 dasiprotimut-t:ql03ax90 feline interleukin-2 recombinant canarypox virus==references==
509